FOG-As-PD: Freezing of Gait and Cognition

Sponsor
Ospedale Generale Di Zona Moriggia-Pelascini (Other)
Overall Status
Completed
CT.gov ID
NCT03477578
Collaborator
(none)
305
1
3
103.1

Study Details

Study Description

Brief Summary

The study was aimed to investigate the role of cognition n in FoG.

Condition or Disease Intervention/Treatment Phase
  • Other: freezers
  • Other: non freezers

Detailed Description

Alteration of cortical circuits in PD leads to cognitive dysfunctions associated with the development of FoG.

The study was aimed to investigate the role of cognition in FoG.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
305 participants
Observational Model:
Case-Control
Time Perspective:
Other
Official Title:
Freezing of Gait and Cognition: What Can we Learn From Cognition?
Actual Study Start Date :
Dec 1, 2017
Actual Primary Completion Date :
Feb 28, 2018
Actual Study Completion Date :
Mar 1, 2018

Arms and Interventions

Arm Intervention/Treatment
FoG+

Parkinsonian patients with Freezing of Gait

Other: freezers
neuropsychological evaluation

Other: non freezers
neuropsychological evaluation

FoG-

Parkinsonian patients withou Freezing of Gait

Other: freezers
neuropsychological evaluation

Other: non freezers
neuropsychological evaluation

Outcome Measures

Primary Outcome Measures

  1. UPDRS [5 years]

    Unified Parkinson's DIsease Rating Scale

  2. MMSE [5 years]

    Mini-Mental State Examination

  3. FAB [5 years]

    Frontal Behavioural Assessment

  4. WCST [5 years]

    Wisconsin Card Sorting Test

  5. TMT A-B [5 years]

    Trial Making Test A and B

  6. Rey Auditory-Verbal Learning Test [5 years]

    RAVLT

Secondary Outcome Measures

  1. 6MWT [5 years]

    Six-Minute Walk Test

  2. TUG [5 years]

    Timed Up and Go Test

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
  • Diagnosis of idiopathic Parkinson's disease according to Gelb et al.
Exclusion Criteria:
  • Any other neurological conditions other than PD

Contacts and Locations

Locations

Site City State Country Postal Code
1 "Moriggia-Pelascini" Hospital Gravedona Ed Uniti CO Italy 22015

Sponsors and Collaborators

  • Ospedale Generale Di Zona Moriggia-Pelascini

Investigators

  • Principal Investigator: Giuseppe Frazzitta, MD, Department of Parkinson's disease, Movement Disorders and Brain Injury Rehabilitation, "Moriggia-Pelascini" Hospital - Via Pelascini, 3, 22015, Gravedona ed Uniti, Como, Italy

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ospedale Generale Di Zona Moriggia-Pelascini
ClinicalTrials.gov Identifier:
NCT03477578
Other Study ID Numbers:
  • FOG-As-PD
First Posted:
Mar 26, 2018
Last Update Posted:
Jul 11, 2019
Last Verified:
Jul 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 11, 2019